"Performance" Peijia Medical's annual loss narrowed to 203 million yuan
PEIJIA Medical-B (09996.HK) announced its 2025 annual performance, with revenue recorded at RMB 713 million, an increase of 15.8% year-on-year. The loss narrowed from RMB 227 million in the previous year to RMB 203 million, with a loss per share of 31 cents. No final dividend is declared
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments